Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

Wyeth is now a wholly owned subsidiary of Pfizer28 enrolled

Overview

The primary purpose is to determine bioavailability of Bazedoxifene/conjugated estrogen formulations for future testing purposes.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Sex: FEMALEMin age: 45 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy, post menopausal women ages 45 to 70 Exclusion Criteria: * Male subjects

Bioavailability

Safety & tolerability

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.